About: BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.02 (+1.00%)
BLRX NASDAQ BioLineRx Ltd
BioLineRx Ltd share price
Atividade de preço de BLRX
Último preço
$ 2,020
Variação (24h)
0,02 USD (1,00%)
Volume
4.15K
Volume (média 4 sem.)
-
Abertura
$ 2,01
Variação do dia
$ 1,94 - $ 2,02
Fechamento anterior
$ 2,00
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
BLRX price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals